Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach

  • Posted on: 5 October 2015
  • By: fcoldren
TitleRelating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach
Publication TypeJournal Article
Year of Publication2015
AuthorsLiu T, Altman RB
JournalJ Chem Inf Model
Date Published2015 Jul 27

The molecular mechanism of many drug side-effects is unknown and difficult to predict. Previous methods for explaining side-effects have focused on known drug targets and their pathways. However, low affinity binding to proteins that are not usually considered drug targets may also drive side-effects. In order to assess these alternative targets, we used the 3D structures of 563 essential human proteins systematically to predict binding to 216 drugs. We first benchmarked our affinity predictions with available experimental data. We then combined singular value decomposition and canonical component analysis (SVD-CCA) to predict side-effects based on these novel target profiles. Our method predicts side-effects with good accuracy (average AUC: 0.82 for side effects present in <50% of drug labels). We also noted that side-effect frequency is the most important feature for prediction and can confound efforts at elucidating mechanism; our method allows us to remove the contribution of frequency and isolate novel biological signals. In particular, our analysis produces 2768 triplet associations between 50 essential proteins, 99 drugs, and 77 side-effects. Although experimental validation is difficult because many of our essential proteins do not have validated assays, we nevertheless attempted to validate a subset of these associations using experimental assay data. Our focus on essential proteins allows us to find potential associations that would likely be missed if we used recognized drug targets. Our associations provide novel insights about the molecular mechanisms of drug side-effects and highlight the need for expanded experimental efforts to investigate drug binding to proteins more broadly.

Alternate JournalJ Chem Inf Model
PubMed ID26121262
Grant ListGM072970 / GM / NIGMS NIH HHS / United States
GM102365 / GM / NIGMS NIH HHS / United States
U54 HL117798 / HL / NHLBI NIH HHS / United States